Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:TRIL
Delisted

Trillium Therapeutics Inc. Stock Price (Quote)

$18.44
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $18.44 $18.44 Friday, 27th May 2022 TRIL stock ended at $18.44. During the day the stock fluctuated 0% from a day low at $18.44 to a day high of $18.44.
90 days $18.44 $18.44
52 weeks $5.80 $18.49

Historical Trillium Therapeutics Inc. prices

Date Open High Low Close Volume
Sep 17, 2021 $17.35 $17.36 $17.22 $17.34 2 606 100
Sep 16, 2021 $17.40 $17.40 $17.28 $17.30 1 537 500
Sep 15, 2021 $17.33 $17.45 $17.26 $17.43 1 028 800
Sep 14, 2021 $17.33 $17.42 $17.30 $17.36 3 320 500
Sep 13, 2021 $17.33 $17.39 $17.20 $17.20 1 582 900
Sep 10, 2021 $17.37 $17.37 $16.91 $17.29 1 992 400
Sep 09, 2021 $17.36 $17.40 $17.28 $17.33 1 821 007
Sep 08, 2021 $17.34 $17.41 $17.28 $17.35 1 803 180
Sep 07, 2021 $17.37 $17.41 $17.31 $17.34 2 520 281
Sep 03, 2021 $17.40 $17.44 $17.33 $17.38 2 204 213
Sep 02, 2021 $17.42 $17.48 $17.34 $17.35 1 933 257
Sep 01, 2021 $17.29 $17.40 $17.24 $17.39 1 901 773
Aug 31, 2021 $17.21 $17.35 $17.21 $17.23 2 453 654
Aug 30, 2021 $17.32 $17.38 $17.03 $17.27 3 119 660
Aug 27, 2021 $17.38 $17.48 $17.30 $17.32 5 227 369
Aug 26, 2021 $17.38 $17.50 $17.25 $17.39 4 942 467
Aug 25, 2021 $17.50 $17.63 $17.30 $17.34 7 552 335
Aug 24, 2021 $17.61 $17.65 $17.46 $17.48 14 878 158
Aug 23, 2021 $17.72 $17.76 $17.37 $17.59 69 845 934
Aug 20, 2021 $5.83 $6.16 $5.80 $6.09 469 040
Aug 19, 2021 $6.27 $6.32 $5.84 $5.86 756 868
Aug 18, 2021 $6.23 $6.55 $6.19 $6.35 589 246
Aug 17, 2021 $6.33 $6.33 $6.00 $6.25 1 015 425
Aug 16, 2021 $6.26 $6.54 $6.05 $6.39 814 556
Aug 13, 2021 $6.18 $6.49 $6.00 $6.23 765 430
Click to get the best stock tips daily for free!

About Trillium Therapeutics Inc.

Trillium Therapeutics. Trillium Therapeutics Inc., an immuno-oncology company, develops therapies for the treatment of cancer. The company’s lead program is SIRPaFc, an antibody-like fusion protein, which is in Phase I clinical trial that blocks the activity of CD47 to promote the macrophage-mediated killing of tumor cells in a range of cancers. It also develops CD200 monoclonal antibody that blocks the activity of CD200 to evade attack from the immune system. The com... TRIL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT